What is Eikon Therapeutics, Inc. 's capex?

Eikon Therapeutics, Inc. (EIKN) reported capex of $262K in Q1 2026.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

MYR GroupMYRG

$16.13M+23.5%

Cabot CorporationCBT

$45M-37.5%

UnifirstUNF

$38.4M+18.1%

HES

Hess MidstreamHESM

$28.8M-36.7%

Warrior Met CoalHCC

$80.13M+17.0%

Piper SandlerPIPR

$2.16M-80.7%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's capex?: Eikon Therapeutics, Inc. (EIKN) reported capex of $262K in Q1 2026.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.